You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nanrilkefusp alfa

Showing 1 - 25 of 1,365
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer Trial (SOT101, Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Dec 5, 2022

Hypophosphatasia Trial in Worldwide (ALXN1850, asfotase alfa)

Not yet recruiting
  • Hypophosphatasia
  • Hartford, Connecticut
  • +29 more
Oct 6, 2023

Fabry Disease Under Enzyme Replacement Therapy With

Recruiting
  • Fabry Disease
  • Berlin, Germany
  • +7 more
Oct 17, 2023

Hypophosphatasia Trial in Würzburg (Ilofotase Alfa, 0.8 mg/kg, Ilofotase Alfa, 3.2 mg/kg)

Recruiting
  • Hypophosphatasia
  • Ilofotase Alfa, 0.8 mg/kg
  • Ilofotase Alfa, 3.2 mg/kg
  • Würzburg, Germany
    Osteologie / Klinische Studieneinheit, Orthopädische Klinik - KL
May 26, 2023

Outcomes in Hospitalised Patients Treated With Ondexxya

Not yet recruiting
  • Hemorrhage
  • Andexanet alfa
  • (no location specified)
Jun 12, 2023

Urgent Surgery Trial (Andexanet alfa, Usual Care)

Not yet recruiting
  • Urgent Surgery
  • Andexanet alfa
  • Usual Care
  • (no location specified)
Jun 21, 2023

Efanesoctocog Alfa on Long-term Joint Health in Hemophilia A

Not yet recruiting
  • Hemophilia A
  • Efanesoctocog Alfa BIVV001
  • (no location specified)
Jun 19, 2023

Glycogen Storage Disease Type II Pompe Disease Trial in Worldwide (GZ402666)

Completed
  • Glycogen Storage Disease Type II Pompe Disease
  • Phoenix, Arizona
  • +16 more
Dec 14, 2022

Multiple Myeloma Trial in Worldwide (Modakafusp alfa, Lenalidomide, Bortezomib)

Recruiting
  • Multiple Myeloma
  • Modakafusp alfa
  • +5 more
  • Little Rock, Arkansas
  • +53 more
Jan 12, 2023

Anemia Trial in Anyang-si (Ferric Derisomaltose Injection, Darbepoetin Alfa Injection)

Recruiting
  • Anemia
  • Ferric Derisomaltose Injection
  • Darbepoetin Alfa Injection
  • Anyang-si, Korea, Republic of
    Hallym University Medical Center
Mar 13, 2023

Multiple Myeloma Trial in Worldwide (Modakafusp Alfa, Daratumumab)

Recruiting
  • Multiple Myeloma
  • Gilbert, Arizona
  • +40 more
Jan 23, 2023

Glycogen Storage Disease Type II-Pompe's Disease Trial in Worldwide (Avalglucosidase alfa (GZ402666), Alglucosidase alfa

Active, not recruiting
Has Results
  • Glycogen Storage Disease Type II-Pompe's Disease
  • Avalglucosidase alfa (GZ402666)
  • Alglucosidase alfa (GZ419829)
  • Valhalla, New York
  • +9 more
May 3, 2022

Damoctocog Alfa Pegol, How it is Used in Every Day Practice, and

Not yet recruiting
  • Hemophilia A
  • No intervention
  • Sacramento, California
  • +2 more
Jan 10, 2023

Anaemia Trial in Fort Worth, Lufkin, San Antonio (Daprodustat, rhEPO, Ferrous sulfate containing the stable iron isotope (57Fe))

Completed
  • Anaemia
  • Fort Worth, Texas
  • +2 more
Oct 20, 2022

Cognitive Remote Assessment Using FLAME (CRA-FLAME)

Enrolling by invitation
  • Cognitive Impairment
  • Remote cognitive testing
  • Barcelona, Spain
    BarcelonaBeta Brain Research Center
Nov 17, 2022

Glycogen Storage Disease Type II Trial in Worldwide (Alglucosidase alfa GZ419829)

Recruiting
  • Glycogen Storage Disease Type II
  • Alglucosidase alfa GZ419829
  • Leuven, Belgium
  • +8 more
Jan 17, 2023

Turoctocog Alfa in Haemophilic Italian Patients: Protection and

Enrolling by invitation
  • Haemophilia A
  • Turoctocog alfa
  • Milano, MI, Italy
  • +9 more
Jan 12, 2023

Adult and Pediatric Acid Sphingomyelinase Deficiency on Early

Recruiting
  • Acid Sphingomyelinase Deficiency (ASMD)
  • Olipudase alfa
  • France, France
    Investigational site number France
Jun 13, 2022

Metastatic Cutaneous Melanoma, Metastatic Mucosal Melanoma, Metastatic Non-Cutaneous Melanoma Trial in Canada, Ireland, United

Active, not recruiting
  • Metastatic Cutaneous Melanoma
  • +15 more
  • Ipilimumab
  • +3 more
  • Birmingham, Alabama
  • +582 more
Jan 28, 2023

Hypophosphatasia Trial (methotrexate, rituximab, bortezomib)

Not yet recruiting
  • Hypophosphatasia
  • (no location specified)
Aug 23, 2023

Acute Graft-versus-host Disease Trial in United States (Efmarodocokin Alfa)

Active, not recruiting
  • Acute Graft-versus-host Disease
  • Efmarodocokin Alfa
  • Duarte, California
  • +7 more
Dec 6, 2022

Hypophosphatasia Trial in Worldwide (ALXN1850, Placebo)

Not yet recruiting
  • Hypophosphatasia
  • Baltimore, Maryland
  • +39 more
Oct 6, 2023

Avalglucosidase Alfa Pregnancy Study

Recruiting
  • Pompe Disease
  • Pregnancy
  • avalglucosidase alfa-NGPT (GZ402666) IV
  • avalglucosidase alfa-NGPT (GZ402666)
  • Bridgewater, New Jersey
    Investigational site worldwide
Feb 15, 2023

Hypophosphatasia Trial in Worldwide (ALXN1850, Placebo)

Not yet recruiting
  • Hypophosphatasia
  • Indianapolis, Indiana
  • +90 more
Oct 6, 2023

Active Systemic Lupus Erythematosus Trial in Worldwide (Efavaleukin Alfa, Placebo, Standard of Care)

Recruiting
  • Active Systemic Lupus Erythematosus
  • Efavaleukin Alfa
  • +2 more
  • Birmingham, Alabama
  • +148 more
Jan 18, 2023